Cargando…
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study
BACKGROUND: Complex regional pain syndrome type-1 (CRPS-1) is a severely disabling painful disease challenging to treat. This multicenter, randomized, double-blind placebo-controlled trial examined the efficacy of intramuscular (i.m.) neridronate in CRPS-1 patients. METHODS: A total of 78 patients d...
Autores principales: | Varenna, Massimo, Braga, Vania, Gatti, Davide, Iolascon, Giovanni, Frediani, Bruno, Zucchi, Francesca, Crotti, Chiara, Nannipieri, Fabrizio, Rossini, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202309/ https://www.ncbi.nlm.nih.gov/pubmed/34178124 http://dx.doi.org/10.1177/1759720X211014020 |
Ejemplares similares
-
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study
por: Varenna, Massimo, et al.
Publicado: (2022) -
Clinical development of neridronate: potential for new applications
por: Gatti, Davide, et al.
Publicado: (2013) -
Neridronate for transient osteoporosis of the hip in a child
por: Gaggiano, C., et al.
Publicado: (2022) -
The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain
por: Iolascon, Giovanni, et al.
Publicado: (2022) -
Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study
por: Guiducci, L., et al.
Publicado: (2019)